** Shares of INOVIQ IIQ.AX fall as much as 2.5% to A$0.390, marking their lowest since Aug 6
** Last down 1.3%
** Cancer therapy co FY net loss after tax widens to A$6.9 million ($4.43 million) from A$6.6 million
** On a weekly basis, shares down nearly 7%, set for worst since week-ending June 20
** Stock down 23.3% YTD, including moves in current session
($1 = 1.5584 Australian dollars)
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((JasmeenAraIslam.Shaikh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.